Breast Cancer Research and Treatment 2014-Nov
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies.
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard